JP Morgan Chase’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-36,000
Closed -$2.4M 5157
2016
Q4
$2.4M Hold
36,000
﹤0.01% 2951
2016
Q3
$2.38M Buy
+36,000
New +$2.46M ﹤0.01% 2695

Other funds holding MD

JP Morgan Chase's MD Position: Q1 2026 in Review

JP Morgan Chase reduced its Pediatrix Medical (MD) stake by 67% in Q1 2026, selling an estimated $9.94M and leaving 232,955 shares worth $4.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3340.

JP Morgan Chase first reported a position in MD in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.9M in Q1 2018. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • JP Morgan Chase held 232,955 shares of Pediatrix Medical worth $4.85M as of Q1 2026.
  • JP Morgan Chase sold 477,762 Pediatrix Medical shares in Q1 2026, an estimated $9.94M.
  • Pediatrix Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3340 holding.
  • JP Morgan Chase first reported a position in Pediatrix Medical in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Pediatrix Medical position peaked at $35.9M in Q1 2018.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.